Unknown

Dataset Information

0

Synthesis, Crystal Structure, and Biological Evaluation of Fused Thiazolo[3,2-a]Pyrimidines as New Acetylcholinesterase Inhibitors.

ABSTRACT: A new series of thiazolo[3,2-a]pyrimidine bromide salt derivatives 7a-d were synthesized from 3,4-dihydropyrimidinethione precursors. The target compounds were fully characterized by 1D- and 2D-NMR, high resolution ESI-MS/MS and single crystal X-ray diffraction analysis, which confirmed a regioselective 5H cyclization of the dihydropyrimidinethiones. All target compounds were evaluated in vitro as human acetylcholinesterase (hAChE) inhibitors via an Ellman-based colorimetric assay and showed good inhibition activities (better than 70% at 10 µM and IC50 values in the 1 µM range). Molecular docking simulations for all target products into hAChE were performed and confirmed strong binding to the enzyme. These results provide a promising and new starting point to improve acetylcholinesterase inhibitors and explore novel treatment options against Alzheimer's disease.

SUBMITTER: Mahgoub MY 

PROVIDER: S-EPMC6630738 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Synthesis, Crystal Structure, and Biological Evaluation of Fused Thiazolo[3,2-<i>a</i>]Pyrimidines as New Acetylcholinesterase Inhibitors.

Mahgoub Mohamed Y MY   Elmaghraby Awatef M AM   Harb Abd-Elfttah A AA   Ferreira da Silva João L JL   Justino Gonçalo C GC   Marques M Matilde MM  

Molecules (Basel, Switzerland) 20190621 12

A new series of thiazolo[3,2-<i>a</i>]pyrimidine bromide salt derivatives <b>7a</b>-<b>d</b> were synthesized from 3,4-dihydropyrimidinethione precursors. The target compounds were fully characterized by 1D- and 2D-NMR, high resolution ESI-MS/MS and single crystal X-ray diffraction analysis, which confirmed a regioselective 5<i>H</i> cyclization of the dihydropyrimidinethiones. All target compounds were evaluated in vitro as human acetylcholinesterase (<i>h</i>AChE) inhibitors via an Ellman-base  ...[more]

Similar Datasets

Unknown Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2-<i>a</i>] pyrimidines as topoisomerase II inhibitors.
| S-EPMC9930781 | biostudies-literature
Unknown Synthesis and biological evaluation of thiophene derivatives as acetylcholinesterase inhibitors.
| S-EPMC6268334 | biostudies-literature
Unknown Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic Acid Derivatives.
| S-EPMC7144117 | biostudies-literature
Unknown Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors.
| S-EPMC6273369 | biostudies-literature
Unknown Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase Inhibitors.
| S-EPMC8320107 | biostudies-literature
Unknown Synthesis of new functionalized thiazolo pyridine-fused and thiazolo pyridopyrimidine-fused spirooxindoles via one-pot reactions.
| S-EPMC7114753 | biostudies-literature
Unknown Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma.
| S-EPMC6543826 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.
| S-EPMC3885252 | biostudies-literature
Unknown Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.
| S-EPMC3782361 | biostudies-literature
Unknown Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold.
| S-EPMC8400540 | biostudies-literature